Michele Bartoletti
-
- Antibiotic Use and Resistance 21
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 34
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 17
- Hepatology top 2%
- Liver Disease and Transplantation 16
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 24
-
- COVID-19 Clinical Research Studies 14
- Antimicrobial Resistance in Staphylococcus 12
-
- Pneumonia and Respiratory Infections 11
- Co-authors
- Pierluigi VialeMaddalena GiannellaSara TedeschiRussell E. LewisSimone AmbrettiPaolo GaibaniLinda BussiniFrancesco Cristini
- Journals
- Clinical Microbiology and Infection (16 papers)Journal of Antimicrobial Chemotherapy (6 papers)International Journal of Antimicrobial Agents (4 papers)
- Partner nations
- ItalySpainUnited States
In The Last Decade
Michele Bartoletti
114 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Applied Microbiology and Biotechnology 754
- Molecular Medicine 1.4k
- Clinical Biochemistry 451
- Hepatology 404
- Pharmacology 833
Countries citing papers authored by Michele Bartoletti
This map shows the geographic impact of Michele Bartoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bartoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bartoletti more than expected).
Fields of papers citing papers by Michele Bartoletti
This network shows the impact of papers produced by Michele Bartoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bartoletti. The network helps show where Michele Bartoletti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michele Bartoletti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 14 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 10 | |
| 15 | 2022 | 10 | |
| 16 | 2021 | 38 | |
| 17 | 2021 | 5 | |
| 18 | 2021 | 50 | |
| 19 | 2020 | 2 | |
| 20 | Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre studybreakdown → | 2015 | 395 |
About Michele Bartoletti
Michele Bartoletti is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 123 papers that have together received 3.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (34 papers), Antibiotics Pharmacokinetics and Efficacy (24 papers), Antibiotic Use and Resistance (21 papers), Bacterial Identification and Susceptibility Testing (17 papers), Liver Disease and Transplantation (16 papers), COVID-19 Clinical Research Studies (14 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and Pneumonia and Respiratory Infections (11 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (754 citations), Molecular Medicine (1.4k citations) and Clinical Biochemistry (451 citations). Michele Bartoletti has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Pierluigi Viale, Maddalena Giannella, Sara Tedeschi, Russell E. Lewis, Simone Ambretti, Paolo Gaibani, Linda Bussini, Francesco Cristini, Fabio Tumietto and Renato Pascale. Their work appears in journals such as Clinical Microbiology and Infection, Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, European Journal of Clinical Microbiology & Infectious Diseases and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.